News

In this video interview, Melissa Stenstrom, MD, previews what she is most excited about at the upcoming American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021

This week’s edition of The Mainstream Patient features stories on the skin barrier, cellulite treatments, tranexamic acid, sun poisoning symptoms, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes new safety data on baricitinib for atopic dermatitis, low malignancy risk for secukinumab in psoriasis, new columns, video coverage from the Inaugural Symposium for Inflammatory Skin Disease, plus more.

In this video interview, Linda Stein Gold, MD, discusses her recent presentation at the Inaugural SISD regarding using topicals for atopic dermatitis.

In this month's Cosmetic Conundrums column, Dermatology Times Chief Medical Editor Zoe Diana Draelos, MD, discusses how to solve common challenges associated with pierced earrings.

This week’s edition of The Mainstream Patient features stories on fraxel lasers, microcurrent facials, perioral dermatitis, brow lifts, plus more.

Given the high prevalence of Kawasaki disease during the pandemic, Japanese investigators determined that droplet or contact transmission of pathogens is likely not a major route causing the development of the disease.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes stories on the cyberwar against health care practices, the link between oxytocin and skin aging, baricitinib for alopecia areata, plus more.

Timber Pharmaceuticals's phase 2b trial of isotretinoin for congenital ichthyosis (CI) has reached 50% enrollment.

A recent study in the Journal of Cosmetic Dermatology examines the safety and efficacy of using vitamin D intralesional injection for the treatment of keloid scars.

This week’s edition of The Mainstream Patient features stories on sweat reduction, vitamin C serums and sensitive skin, the importance of sebum, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes what FDA approvals to watch for in April, trending skin care, navigating the match process, plus more.

The AAD announced it will begin accepting applications soon for its 2021 Hair Loss and Alopecia Initiative in Research (HAIR) Grant Program, which focuses on helping fund research for hair disorders, especially in diverse populations.

Explore the dermatologic drugs the FDA will make a decision to approve during April 2021.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of April.

In this video interview, Jay Wofford, MD, FAAD, provides some insightful tips on how to navigate the match process.

This week’s edition of The Mainstream Patient features stories on facial cupping, hyperpigmentation on darker skin types, mushrooms in skincare, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes 2021 updates for acne, the link between collagen degeneration and rosacea, the effects of COVID-19 on the healthcare industry, plus more.

An online survey conducted in late-2020 shows what drove vaccine hesitancy.

In late 2020, our sister publication, Medical Economics®, conducted a Physicians Report asking physician audiences what they thought would be the most challenging issues they will face this year. Here is what the respondents said.

This was the first genome-wide association study of skin pigmentation in African Americans, according to the study authors.

This week’s edition of The Mainstream Patient features stories on aloe vera in skincare, fungal acne, the COVID-19 plastic surgery boom, plus more.

A glimpse at what to expect from Dermatology Times this week.

ICYMI, some of this week’s featured content includes a new podcast episode and stories on a new E-BPO for rosacea, a quick guide to regenerative aesthetic medicine, cutaneous side effects seen in COVID vaccine patients, plus more.

Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose. Experts assure that while the delayed side effect is uncomfortable, it is temporary and can be treated at home.

This week’s edition of The Mainstream Patient features stories on pore vacuums, psoriasis on POC skin, the difference between fillers and Botox, how to treat scars, plus more.